Polymyxin Methylene Sulfonic Acid (Aremyxin) in the Treatment of Infections with Gram-Negative Organisms View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1976

AUTHORS

J. Modaï , F. Vachon , J. Frottier

ABSTRACT

Polymyxin Sulfonic Acid (Aremyxin) was administered to 40 patients suffering from infections due to gram — organisms (24 cases of urinary infection and 16 of septicaemia). At a dose of 20,000 to 30,000 U/kg/day, cure was obtained in 31 patients, 15 of which were cases of septicaemia. In 12 cases it was used together with another antibiotic (carbenicillin or aminoside). Failures were due either to microbial resistance or to a change of organism. Renal impairment, present in 5 patients, resolved completely in all cases when treatment was discontinued. The substance may be given at lower doses to patients with renal insufficiency. More... »

PAGES

163-167

Book

TITLE

Chemotherapy

ISBN

978-1-4613-4348-6
978-1-4613-4346-2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4613-4346-2_25

DOI

http://dx.doi.org/10.1007/978-1-4613-4346-2_25

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011394799


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Claude Bernard Hospital, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Claude Bernard Hospital, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moda\u00ef", 
        "givenName": "J.", 
        "id": "sg:person.07623513564.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07623513564.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Claude Bernard Hospital, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Claude Bernard Hospital, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vachon", 
        "givenName": "F.", 
        "id": "sg:person.0103442500.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0103442500.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Claude Bernard Hospital, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Claude Bernard Hospital, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frottier", 
        "givenName": "J.", 
        "id": "sg:person.051570254.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.051570254.80"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1976", 
    "datePublishedReg": "1976-01-01", 
    "description": "Polymyxin Sulfonic Acid (Aremyxin) was administered to 40 patients suffering from infections due to gram \u2014 organisms (24 cases of urinary infection and 16 of septicaemia). At a dose of 20,000 to 30,000 U/kg/day, cure was obtained in 31 patients, 15 of which were cases of septicaemia. In 12 cases it was used together with another antibiotic (carbenicillin or aminoside). Failures were due either to microbial resistance or to a change of organism. Renal impairment, present in 5 patients, resolved completely in all cases when treatment was discontinued. The substance may be given at lower doses to patients with renal insufficiency.", 
    "editor": [
      {
        "familyName": "Williams", 
        "givenName": "J. D.", 
        "type": "Person"
      }, 
      {
        "familyName": "Geddes", 
        "givenName": "A. M.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4613-4346-2_25", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4613-4348-6", 
        "978-1-4613-4346-2"
      ], 
      "name": "Chemotherapy", 
      "type": "Book"
    }, 
    "keywords": [
      "cases of septicaemia", 
      "treatment of infections", 
      "Gram-negative organisms", 
      "renal impairment", 
      "renal insufficiency", 
      "low doses", 
      "patients", 
      "infection", 
      "microbial resistance", 
      "treatment", 
      "changes of organisms", 
      "septicaemia", 
      "insufficiency", 
      "doses", 
      "dose", 
      "impairment", 
      "cases", 
      "cure", 
      "days", 
      "sulfonic acid", 
      "failure", 
      "acid", 
      "substances", 
      "organisms", 
      "resistance", 
      "changes", 
      "Polymyxin Sulfonic Acid", 
      "Polymyxin Methylene Sulfonic Acid", 
      "Methylene Sulfonic Acid"
    ], 
    "name": "Polymyxin Methylene Sulfonic Acid (Aremyxin) in the Treatment of Infections with Gram-Negative Organisms", 
    "pagination": "163-167", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011394799"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4613-4346-2_25"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4613-4346-2_25", 
      "https://app.dimensions.ai/details/publication/pub.1011394799"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-12-01T20:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/chapter/chapter_231.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4613-4346-2_25"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-4346-2_25'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-4346-2_25'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-4346-2_25'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4613-4346-2_25'


 

This table displays all metadata directly associated to this object as RDF triples.

108 TRIPLES      23 PREDICATES      55 URIs      48 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4613-4346-2_25 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Ne9b862d9dd844160adc3a0ff8f0d4368
4 schema:datePublished 1976
5 schema:datePublishedReg 1976-01-01
6 schema:description Polymyxin Sulfonic Acid (Aremyxin) was administered to 40 patients suffering from infections due to gram — organisms (24 cases of urinary infection and 16 of septicaemia). At a dose of 20,000 to 30,000 U/kg/day, cure was obtained in 31 patients, 15 of which were cases of septicaemia. In 12 cases it was used together with another antibiotic (carbenicillin or aminoside). Failures were due either to microbial resistance or to a change of organism. Renal impairment, present in 5 patients, resolved completely in all cases when treatment was discontinued. The substance may be given at lower doses to patients with renal insufficiency.
7 schema:editor Ne356a7cc87034bd09bfc6fe47e44ea25
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N4c87dc46cb6f4268b30a458a051e2202
12 schema:keywords Gram-negative organisms
13 Methylene Sulfonic Acid
14 Polymyxin Methylene Sulfonic Acid
15 Polymyxin Sulfonic Acid
16 acid
17 cases
18 cases of septicaemia
19 changes
20 changes of organisms
21 cure
22 days
23 dose
24 doses
25 failure
26 impairment
27 infection
28 insufficiency
29 low doses
30 microbial resistance
31 organisms
32 patients
33 renal impairment
34 renal insufficiency
35 resistance
36 septicaemia
37 substances
38 sulfonic acid
39 treatment
40 treatment of infections
41 schema:name Polymyxin Methylene Sulfonic Acid (Aremyxin) in the Treatment of Infections with Gram-Negative Organisms
42 schema:pagination 163-167
43 schema:productId N1b9c0e6f9224486c946b4c13be99070c
44 N3270dd6d63364596ae13ef79618edbee
45 schema:publisher N6cb18676d09f4d3e9f47b357d9b0cbf7
46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011394799
47 https://doi.org/10.1007/978-1-4613-4346-2_25
48 schema:sdDatePublished 2021-12-01T20:01
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher N6373422507b549dab884d7a4510670a4
51 schema:url https://doi.org/10.1007/978-1-4613-4346-2_25
52 sgo:license sg:explorer/license/
53 sgo:sdDataset chapters
54 rdf:type schema:Chapter
55 N1b9c0e6f9224486c946b4c13be99070c schema:name dimensions_id
56 schema:value pub.1011394799
57 rdf:type schema:PropertyValue
58 N3270dd6d63364596ae13ef79618edbee schema:name doi
59 schema:value 10.1007/978-1-4613-4346-2_25
60 rdf:type schema:PropertyValue
61 N4c87dc46cb6f4268b30a458a051e2202 schema:isbn 978-1-4613-4346-2
62 978-1-4613-4348-6
63 schema:name Chemotherapy
64 rdf:type schema:Book
65 N6373422507b549dab884d7a4510670a4 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N6cb18676d09f4d3e9f47b357d9b0cbf7 schema:name Springer Nature
68 rdf:type schema:Organisation
69 Na42c92b5ad7441099ad09236dce3118e schema:familyName Williams
70 schema:givenName J. D.
71 rdf:type schema:Person
72 Nad2958a9840746f58197e52531eed40e rdf:first Ndb43b878bbb24878b72dd767a4e8ad30
73 rdf:rest rdf:nil
74 Nb479d665f51b4734af986b5bb05d4c56 rdf:first sg:person.0103442500.80
75 rdf:rest Nfb00147a4eef4da8b00be93eff4d1654
76 Ndb43b878bbb24878b72dd767a4e8ad30 schema:familyName Geddes
77 schema:givenName A. M.
78 rdf:type schema:Person
79 Ne356a7cc87034bd09bfc6fe47e44ea25 rdf:first Na42c92b5ad7441099ad09236dce3118e
80 rdf:rest Nad2958a9840746f58197e52531eed40e
81 Ne9b862d9dd844160adc3a0ff8f0d4368 rdf:first sg:person.07623513564.20
82 rdf:rest Nb479d665f51b4734af986b5bb05d4c56
83 Nfb00147a4eef4da8b00be93eff4d1654 rdf:first sg:person.051570254.80
84 rdf:rest rdf:nil
85 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
86 schema:name Medical and Health Sciences
87 rdf:type schema:DefinedTerm
88 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
89 schema:name Clinical Sciences
90 rdf:type schema:DefinedTerm
91 sg:person.0103442500.80 schema:affiliation grid-institutes:grid.411119.d
92 schema:familyName Vachon
93 schema:givenName F.
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0103442500.80
95 rdf:type schema:Person
96 sg:person.051570254.80 schema:affiliation grid-institutes:grid.411119.d
97 schema:familyName Frottier
98 schema:givenName J.
99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.051570254.80
100 rdf:type schema:Person
101 sg:person.07623513564.20 schema:affiliation grid-institutes:grid.411119.d
102 schema:familyName Modaï
103 schema:givenName J.
104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07623513564.20
105 rdf:type schema:Person
106 grid-institutes:grid.411119.d schema:alternateName Claude Bernard Hospital, Paris, France
107 schema:name Claude Bernard Hospital, Paris, France
108 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...